HUMANA AB Aktie

 

Humana AB (publ) (LEI code 549300A5X3MXUDS67N81) ("Humana") has, on 5 May 2025, repurchased a total of 40,000 own shares (ISIN: SE0008040653) within the framework of the buy-back program initiated by Humana's Board of Directors in order to improve the company's capital structure. The repurchases are part of the buy-back program of a maximum of 1,000,000 own shares for a total amount of up to SEK 52.5 million that Humana announced on 17 March 2025. In accordance with the press release of 20 March 2025, the buy-back program runs from March 20, 2025, until the Annual General Meeting 2025 and is...

Das Instrument 47H SE0008040653 HUMANA AB EQUITY wird ex Dividende/Zinsen gehandelt am 07.05.2025 The instrument 47H SE0008040653 HUMANA AB EQUITY has its ex-dividend/interest day on 07.05.2025...

Humana AB held its annual general meeting on Tuesday, May 6, 2025. The main resolutions passed at the meeting were as follows. Report from the Annual General Meeting of Humana AB held on May 6, 2025   More detailed information about the contents of the resolutions may be obtained from the complete notice of the annual general meeting and the complete proposals. The notice and complete proposals are available on the company's website, https://www.humanagroup.com/.   Adoption of balance sheets and profit and loss accounts It was resolved to adopt the profit and loss account and...

During the period 28 April 2025 to 2 May 2025, Humana AB (publ) (LEI code 549300A5X3MXUDS67N81) ("Humana") has repurchased a total of 133,586 own shares (ISIN: SE0008040653) within the framework of the buy-back program initiated by Humana's Board of Directors in order to improve the company's capital structure. The repurchases are part of the buy-back program of a maximum of 1,000,000 own shares for a total amount of up to SEK 52.5 million that Humana announced on 17 March 2025. In accordance with the press release of 20 March 2025, the buy-back program runs from March 20, 2025, until the...

During the period 22 April 2025 to 25 April 2025, Humana AB (publ) (LEI code 549300A5X3MXUDS67N81) ("Humana") has repurchased a total of 126,371 own shares (ISIN: SE0008040653) within the framework of the buy-back program initiated by Humana's Board of Directors in order to improve the company's capital structure. The repurchases are part of the buy-back program of a maximum of 1,000,000 own shares for a total amount of up to SEK 52.5 million that Humana announced on 17 March 2025. In accordance with the press release of 20 March 2025, the buy-back program runs from March 20, 2025, until the...

During the period 14 April 2025 to 17 April 2025, Humana AB (publ) (LEI code 549300A5X3MXUDS67N81) ("Humana") has repurchased a total of 108,539 own shares (ISIN: SE0008040653) within the framework of the buy-back program initiated by Humana's Board of Directors in order to improve the company's capital structure. The repurchases are part of the buy-back program of a maximum of 1,000,000 own shares for a total amount of up to SEK 52.5 million that Humana announced on 17 March 2025. In accordance with the press release of 20 March 2025, the buy-back program runs from March 20, 2025, until the...

During the period 7 April 2025 to 11 April 2025, Humana AB (publ) (LEI code 549300A5X3MXUDS67N81) ("Humana") has repurchased a total of 181,500 own shares (ISIN: SE0008040653) within the framework of the buy-back program initiated by Humana's Board of Directors in order to improve the company's capital structure. The repurchases are part of the buy-back program of a maximum of 1,000,000 own shares for a total amount of up to SEK 52.5 million that Humana announced on 17 March 2025. In accordance with the press release of 20 March 2025, the buy-back program runs from March 20, 2025, until the...

During the period 31 March 2025 to 4 April 2025, Humana AB (publ) (LEI code 549300A5X3MXUDS67N81) ("Humana") has repurchased a total of 174.646 own shares (ISIN: SE0008040653) within the framework of the buy-back program initiated by Humana's Board of Directors in order to improve the company's capital structure. The repurchases are part of the buy-back program of a maximum of 1,000,000 own shares for a total amount of up to SEK 52.5 million that Humana announced on 17 March 2025. In accordance with the press release of 20 March 2025, the buy-back program runs from March 20, 2025, until the...

During the period 24 March 2025 to 28 March 2025, Humana AB (publ) (LEI code 549300A5X3MXUDS67N81) ("Humana") has repurchased a total of 174.646 own shares (ISIN: SE0008040653) within the framework of the buy-back program initiated by Humana's Board of Directors in order to improve the company's capital structure. The repurchases are part of the buy-back program of a maximum of 1,000,000 own shares for a total amount of up to SEK 52.5 million that Humana announced on 17 March 2025. In accordance with the press release of 20 March 2025, the buy-back program runs from March 20, 2025, until the...

The board of Humana AB has resolved to convene an annual general meeting of shareholders to be held on Tuesday, May 6, 2025. More information about the contents of the proposals may be obtained from the complete notice to the annual general meeting below. The notice is expected to be published in the Swedish Official Gazette (Post- och Inrikes Tidningar) and on the company's website within the next few days. For further information, please contact Ewelina Pettersson, Head of Investor Relations, +46 73 074 79 12, ewelina.pettersson@humana.se English translation for information...

During the period 20 March 2025 to 21 March 2025, Humana AB (publ) (LEI code 549300A5X3MXUDS67N81) ("Humana") has repurchased a total of 56.314 own shares (ISIN: SE0008040653) within the framework of the buy-back program initiated by Humana's Board of Directors in order to improve the company's capital structure. The repurchases are part of the buy-back program of a maximum of 1,000,000 own shares for a total amount of up to SEK 52.5 million that Humana announced on 17 March 2025. In accordance with the press release of 20 March 2025, the buy-back program runs from March 20, 2025, until the...

In accordance with the press release on March 17, 2025, regarding the board's resolution to repurchase own shares, the repurchases of no more than 1,000,000 own shares will commence today. On March 17, 2025, Humana AB (“Humana”) announced that the board, under the authorisation from the annual general meeting 2024, has resolved to repurchase no more than 1,000,000 own shares on Nasdaq Stockholm. Today, the repurchases are initiated, with a maximum acquisition amount of SEK 52.5 million in total. The repurchases are carried out for the purpose of improving the company's capital structure. In...

In accordance with the previously communicated resolution, Humana AB ("Humana") has completed the repurchase of 1,000,000 own shares. Under the authorisation from the annual general meeting 2024, the board of Humana has again resolved to repurchase no more than 1,000,000 own shares for the purpose of enabling the improvement of the company's capital structure and to increase the flexibility for the board in connection with potential future corporate acquisitions. Any repurchase will be made on Nasdaq Stockholm in accordance with the Nordic Main Market Rulebook for Issuers of Shares and take...

Humana AB is expanding its Group executive management and appointing Gabriella Reuterswärd to the role of Chief Marketing Officer. Gabriella Reuterswärd most recently served as Marketing Director at Norlandia Care. Gabriella Reuterswärd has many years of experience in the health and care sector. She has held senior positions at Norlandia Health and Care Group, Frösunda Omsorg and Thomson Reuters. -Humana has ambitious goals to increase its presence and visibility in the markets where we operate. Gabriella has a deep understanding of the industry as well as a drive and curiosity that I am...

Humana AB is expanding its Group executive management and appointing Jonas Jarborn to the role of Chief Quality and Compliance Officer, effective April 28, 2025. Jonas Jarborn most recently served as Strategy and Development Director at Norlandia Care. Jonas Jarborn has many years of experience in the health and care sector, including senior positions at Norlandia Health and Care Group, Frösunda Omsorg and Ambea. -I look forward to welcoming Jonas to us at Humana. Systematic quality work is crucial in the care we provide. By appointing the role of Quality and Compliance Director, we...

The members of the Nomination Committee for Humana AB's Annual General Meeting in 2025 have now been appointed. According to the instructions adopted at the General Meeting Humana AB shall have a Nomination Committee comprising one representative for each of the four principal shareholders in terms of votes and the Chairman of the Board. In the event that a shareholder chooses to refrain representation in the Nomination Committee, if the Nomination Committee deems it appropriate, a representative of the next largest shareholder may be given the opportunity to join. Based on the ownership...

Humana AB has appointed Christoffer Herou in the role as CFO. He will assume the position on September 2, 2024. Christoffer Herou most recently served in the role as Group CFO at C-RAD AB. Christoffer Herou has many years of experience in the social care market, including the position as Group CFO at Frösunda, and leading positions at Norlandia Health Care Group.  -I am glad to be able to welcome Christoffer to us at Humana. Christoffer knows the social care market and has solid experience from leading positions within finance and accounting, most recently from the listed company C-RAD....

Humana has, in accordance with what has previously been disclosed, carried out an issue in kind in connection with the acquisition of Team Olivia Norge AS. Before the issue, there were a total of 47,826,058 shares and votes in Humana AB. The number of shares and votes has increased by 4,000,000 through the issue. The total number of shares and votes in Humana AB amounts to 51,826,058 as of 28 June 2024, the last trading day of the month. For more information, please contact: Johanna Rastad, President & CEO of Humana, +46 707-48 20 44, johanna.rastad@humana.se Ewelina Pettersson,...